Canada markets open in 1 hour 34 minutes
  • S&P/TSX

    19,203.70
    +2.40 (+0.01%)
     
  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     
  • DOW

    33,677.27
    -68.13 (-0.20%)
     
  • CAD/USD

    0.7963
    -0.0018 (-0.22%)
     
  • CRUDE OIL

    61.19
    +1.01 (+1.68%)
     
  • BTC-CAD

    81,229.49
    +2,067.44 (+2.61%)
     
  • CMC Crypto 200

    1,395.42
    +101.43 (+7.84%)
     
  • GOLD FUTURES

    1,745.50
    -2.10 (-0.12%)
     
  • RUSSELL 2000

    2,228.92
    -4.86 (-0.22%)
     
  • 10-Yr Bond

    1.6230
    0.0000 (0.00%)
     
  • NASDAQ futures

    14,021.00
    +45.25 (+0.32%)
     
  • VOLATILITY

    16.64
    -0.27 (-1.60%)
     
  • FTSE

    6,918.39
    +27.90 (+0.40%)
     
  • NIKKEI 225

    29,620.99
    -130.61 (-0.44%)
     
  • CAD/EUR

    0.6659
    -0.0014 (-0.21%)
     

Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Indication, by Workflow, by Application, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19

ReportLinker
·6 min read

Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type (Adeno-Associated Virus, Adenovirus, Lentivirus, and Plasmid DNA), by Indication (Cancer, Genetic Disorder, and Infectious Disease), by Workflow, by Application, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19

New York, April 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Indication, by Workflow, by Application, by End User - United States Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06015233/?utm_source=GNW

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The United States Viral Vector & Plasmid DNA Manufacturing Market is expected to grow from USD 136.80 Million in 2020 to USD 415.57 Million by the end of 2025.
2. The United States Viral Vector & Plasmid DNA Manufacturing Market is expected to grow from EUR 119.95 Million in 2020 to EUR 364.38 Million by the end of 2025.
3. The United States Viral Vector & Plasmid DNA Manufacturing Market is expected to grow from GBP 106.63 Million in 2020 to GBP 323.93 Million by the end of 2025.
4. The United States Viral Vector & Plasmid DNA Manufacturing Market is expected to grow from JPY 14,600.45 Million in 2020 to JPY 44,352.44 Million by the end of 2025.
5. The United States Viral Vector & Plasmid DNA Manufacturing Market is expected to grow from AUD 198.65 Million in 2020 to AUD 603.47 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Viral Vector & Plasmid DNA Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Adeno-Associated Virus is projected to witness the highest growth during the forecast period"

Based on Type, the Viral Vector & Plasmid DNA Manufacturing Market studied across Adeno-Associated Virus, Adenovirus, Lentivirus, and Plasmid DNA. The Lentivirus commanded the largest size in the Viral Vector & Plasmid DNA Manufacturing Market in 2020. On the other hand, the Adeno-Associated Virus is expected to grow at the fastest CAGR during the forecast period.

"The Infectious Disease is projected to witness the highest growth during the forecast period"

Based on Indication, the Viral Vector & Plasmid DNA Manufacturing Market studied across Cancer, Genetic Disorder, and Infectious Disease. The Cancer commanded the largest size in the Viral Vector & Plasmid DNA Manufacturing Market in 2020. On the other hand, the Infectious Disease is expected to grow at the fastest CAGR during the forecast period.

"The Upstream Processing is projected to witness the highest growth during the forecast period"

Based on Workflow, the Viral Vector & Plasmid DNA Manufacturing Market studied across Downstream Processing and Upstream Processing. The Downstream Processing further studied across Fill-finish and Purification. The Upstream Processing further studied across Vector Amplification & Expansion and Vector Recovery/Harvesting. The Downstream Processing commanded the largest size in the Viral Vector & Plasmid DNA Manufacturing Market in 2020. On the other hand, the Upstream Processing is expected to grow at the fastest CAGR during the forecast period.

"The Vaccinology is projected to witness the highest growth during the forecast period"

Based on Application, the Viral Vector & Plasmid DNA Manufacturing Market studied across Antisense & RNAi, Cell Therapy, Gene Therapy, and Vaccinology. The Gene Therapy commanded the largest size in the Viral Vector & Plasmid DNA Manufacturing Market in 2020. On the other hand, the Vaccinology is expected to grow at the fastest CAGR during the forecast period.

"The Research Institutes is projected to witness the highest growth during the forecast period"

Based on End User, the Viral Vector & Plasmid DNA Manufacturing Market studied across Biotech Companies and Research Institutes. The Biotech Companies commanded the largest size in the Viral Vector & Plasmid DNA Manufacturing Market in 2020. On the other hand, the Research Institutes is expected to grow at the fastest CAGR during the forecast period.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:
The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Viral Vector & Plasmid DNA Manufacturing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:
The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the United States Viral Vector & Plasmid DNA Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Viral Vector & Plasmid DNA Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Viral Vector & Plasmid DNA Manufacturing Market?
4. What is the competitive strategic window for opportunities in the United States Viral Vector & Plasmid DNA Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the United States Viral Vector & Plasmid DNA Manufacturing Market?
6. What are the modes and strategic moves considered suitable for entering the United States Viral Vector & Plasmid DNA Manufacturing Market?
Read the full report: https://www.reportlinker.com/p06015233/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001